US SaaS companies should identify where AI features reach EU customers or EU users, whether the company acts as provider or deployer, and which product, documentation or oversight gaps matter before expansion.
Operational information, not legal advice.
Company exposure map
Business context
EU customers, users or output
AI product or workflow use
Exposure path
Strategic answer
US SaaS companies can trigger EU AI Act readiness questions when AI features are sold into Europe, embedded in customer workflows or used by EU users. The key is to clarify product role, customer impact and documentation needs before expansion.
Start with the EU AI Act Diagnostic, turn findings into an implementation plan, and see how the diagnostic works as a reference app on M13.
Exposure focus
First action
This page provides operational information for AI governance readiness. It is not legal advice.
Related guides
Run a diagnostic-first EU AI Act assessment for role, risk, documentation and implementation exposure.
A direct answer page for US companies that need to understand possible EU AI Act exposure.
A US company guide to EU AI Act exposure, diagnostic preparation and implementation order.
A practical guide to assessing EU AI Act risk before committing budget to implementation.
Official sources
External references are included for source orientation. This page remains operational information and is not legal advice.
